Regen BioPharma Inc (RGBP)

[trucker20]

This is back from 2017, but this is one of many types of developments RGBP is in the process of bringing to market, which will benefit many people who are suffering from cancer.

https://www.biospace.com/article/releases/regen-biopharma-research-demonstrates-ex-vivo-immune-suppression-with-novel-nr2f6-activators-/

The NR2F6 nuclear receptor has been identified as a potentially very important immune cell inhibitor (an immune checkpoint) and cancer stem cell differentiator. The NR2F6 program at Regen aims to identify antagonists of NR2F6 in an effort to unleash the cancer-killing potential of a patient's own immune system as well as identifying agonists which should suppress the immune system in diseases where the immune system is over-activated, such as autoimmunity.